Nathan Pennell, MD, Ph.D., GRACE Faculty

Nathan Pennell, MD, Ph.D. Medical Oncology, Internal Medicine
Taussig Cancer Center
Lung cancer, mesothelioma, and thyroid cancer

Dr. Nathan Pennell received his Ph.D. in neuroscience in 1998 and his M.D. in 2002 from the University of Florida College of Medicine in Gainesville, FL. He then moved to Boston to do his internal medicine internship and residency training at Brigham & Women’s Hospital, and completed his medical oncology fellowship at the Dana Farber Cancer Institute, also in Boston. While there, he developed an expertise in lung cancer, mesothelioma, and thyroid cancer. He moved to the friendly midwest in 2008 to continue with this focus at the Taussig Cancer Institute at the Cleveland Clinic.

Dr. Pennell specializes in the treatment of thoracic malignancies with a focus on lung cancer. His research interests include clinical trials using novel therapies, with a goal of facilitating the movement of new treatments from the laboratory to the clinic. GRACE is pleased to welcome Dr. Pennell as a faculty member.

Conflict of Interest


From the GRACE Archives - Originally Published August 26, 2009 | By Dr Pennell 

OK, I hope you all aren’t bored to tears by this topic by now, given two related posts in April and again earlier this month describing the “broken” clinical trials system and the challenges to performing clinical research in the current environment. However, I thought this would be a good follow up post to let all of you know that the laughably obstructionist policies in place that prevent timely processing of clinical trials are being recognized, and that something is being done to fix it.

From the GRACE Archives - Originally Published April 11, 2009 | By Dr Pennell 

Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses new options in acquired resistance for ALK positive non-small cell lung cancer (NSCLC).

Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses the role for immunotherapy in patients with a driver mutation.

Community Forum


Thought I should add that I am 65, former 30 yr smoker quit 8 yrs ago. Otherwise active and decent health. I will welcome any insight/answers to my questions whether to...

Hi and welcome to Grace,

I'm sorry you're going through this scare. I can't say if the 7mm growth in 7 years will or won't be a problem in the rather...

How does this forum work. Are community members able to reply to posts, or just moderators? Thanks

Usually the conversation is between the op and mod and/or faculty though we would like to have other members join in to share experiences, knowledge, and support. more heads are better...

Hi Michel, Welcome to Grace though I'm very sorry you are here.

Blood/liquid biopsies can detect cancer cells but usually only if there are a lot of cancer cells circulating. So...